| 1 |
Maeta M, Miura N, Tanaka H, Nakamura T, Kawanishi R, Nishikawa Y, Asano K, Tanaka M, Tamagawa S, Nakai Y, Tange K, Yoshioka H, Harashima H, Akita H. Vitamin E Scaffolds of pH-Responsive Lipid Nanoparticles as DNA Vaccines in Cancer and Protozoan Infection. Mol Pharm 2020;17:1237-47. [PMID: 32129629 DOI: 10.1021/acs.molpharmaceut.9b01262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 2 |
Wu L, Yang H, Wang J, Yu X, He Y, Chen S. A Novel Combined DNA Vaccine Encoding Toxoplasma gondii SAG1 and ROP18 Provokes Protective Immunity Against a Lethal Challenge in Mice. Acta Parasitol 2021;66:1387-95. [PMID: 34019277 DOI: 10.1007/s11686-021-00415-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Warner RC, Chapman RC, Davis BN, Davis PH. REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII. J Parasitol 2021;107:882-903. [PMID: 34852176 DOI: 10.1645/20-157] [Reference Citation Analysis]
|
| 4 |
Mamaghani AJ, Fathollahi A, Arab-Mazar Z, Kohansal K, Fathollahi M, Spotin A, Bashiri H, Bozorgomid A. Toxoplasma gondii vaccine candidates: a concise review. Ir J Med Sci 2022. [PMID: 35394635 DOI: 10.1007/s11845-022-02998-9] [Reference Citation Analysis]
|
| 5 |
Zhu YC, He Y, Liu JF, Chen J. Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice. Parasite 2020;27:26. [PMID: 32315596 DOI: 10.1051/parasite/2020021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Abebe F. Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: A review of current understanding. Int Rev Immunol 2019;38:172-9. [PMID: 31244354 DOI: 10.1080/08830185.2019.1632842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 7 |
Xu H, Xing J, Tang X, Sheng X, Zhan W. Generation and functional evaluation of a DNA vaccine co-expressing Vibrio anguillarum VAA protein and flounder interleukin-2. Fish Shellfish Immunol 2019;93:1018-27. [PMID: 31446082 DOI: 10.1016/j.fsi.2019.08.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 8 |
Zheng B, Lou D, Ding J, Zhuo X, Ding H, Kong Q, Lu S. GRA24-Based DNA Vaccine Prolongs Survival in Mice Challenged With a Virulent Toxoplasma gondii Strain. Front Immunol 2019;10:418. [PMID: 30894865 DOI: 10.3389/fimmu.2019.00418] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 9 |
Smith NC, Goulart C, Hayward JA, Kupz A, Miller CM, van Dooren GG. Control of human toxoplasmosis. Int J Parasitol 2021;51:95-121. [PMID: 33347832 DOI: 10.1016/j.ijpara.2020.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 10 |
Hajissa K, Zakaria R, Suppian R, Mohamed Z. Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: A mini-review. J Adv Vet Anim Res 2019;6:174-82. [PMID: 31453188 DOI: 10.5455/javar.2019.f329] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 11 |
Loh FK, Nathan S, Chow SC, Fang CM. Vaccination challenges and strategies against long-lived Toxoplasma gondii. Vaccine 2019;37:3989-4000. [PMID: 31186188 DOI: 10.1016/j.vaccine.2019.05.083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
